Feb 14, 2023 / 08:00AM GMT
Presentation
Feb 14, 2023 / 08:00AM GMT
=====================
Corporate Participants
=====================
* Chris Cargill
Sosei Group Corporation - Representative Executive Officer, President, CEO & Director
* Hironoshin Nomura
Sosei Group Corporation - Senior VP of IR, VP & Corporate Strategy, Executive Officer and CFO
* Matt Barnes
Sosei Group Corporation - Head of Drug Discovery, Exec. Officer, VP, President of Heptares Therapeutics Ltd. & Head of UK R&D
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Naoya Miura
Jefferies LLC, Research Division - Equity Analyst
* Shinya Tsuzuki
Mizuho Securities Co., Ltd., Research Division - Analyst
=====================
Hironoshin Nomura - Sosei Group Corporation - Senior VP of IR, VP & Corporate Strategy
Nxera Pharma Co Ltd
(OTCPK:SOLTF)
$
8.052
0.422 (5.53%)
Market Cap: 701.82 Mil
Enterprise Value: 833.17 Mil
PE Ratio: 0
PB Ratio: 1.65
GF Score: 72/100 Full Year 2022 Sosei Group Corp Earnings Presentation Transcript
Feb 14, 2023 / 08:00AM GMT
Release Date Price:
$11.36
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot